| ISSN |
2150-5330 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Review |
| Article Title |
Cholangiocarcinoma and liver transplantation: What we know so far?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Ali Reza Safarpour, Hassan Askari, Farshid Ejtehadi, Asaad Azarnezhad, Ehsan Raeis-Abdollahi, Amir Tajbakhsh, Mohammad Foad Abazari, Firoozeh Tarkesh, Alireza Shamsaeefar, Ramin Niknam, Gholam Reza Sivandzadeh, Kamran Bagheri Lankarani and Fardad Ejtehadi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fardad Ejtehadi, MD, Assistant Professor, Department of Gastroenterohepatology Research Center, Shiraz University of Medical Sciences, Khalili St, Shiraz 7134814336, Iran. edjtehadif@sums.ac.ir |
| Key Words |
Cholangiocarcinoma; Liver transplantation; Primary sclerosing cholangitis; Neoadjuvant chemoradiotherapy |
| Core Tip |
Currently, there are many controversial hypotheses concerning the liver transplantation in cholangiocarcinoma, risk factors and molecular pathogenesis of cholangiocarcinoma, with a focus on primary sclerosing cholangitis. Here, we mainly review the current advances in classification and treatment of CCA. |
| Publish Date |
2021-09-15 09:34 |
| Citation |
Safarpour AR, Askari H, Ejtehadi F, Azarnezhad A, Raeis-Abdollahi E, Tajbakhsh A, Abazari MF, Tarkesh F, Shamsaeefar A, Niknam R, Sivandzadeh GR, Lankarani KB, Ejtehadi F. Cholangiocarcinoma and liver transplantation: What we know so far. World J Gastrointest Pathophysiol 2021; 12(5): 84-105 |
| URL |
https://www.wjgnet.com/2150-5330/full/v12/i5/84.htm |
| DOI |
https://dx.doi.org/10.4291/wjgp.v12.i5.84 |
